retatrutide/cagrilintide Cagrilintide, Tirzepatide, and Retatrutide Peptides: Comparing Metabolic Mechanisms Cagrilintide vs Retatrutide for Weight
Description
Heres what you'll learn: Why GLP-1 receptors throughout the mesolimbic system make these medications psychiatric tools, not just metabolic ones Evidence-based patient selection criteria (mechanism over BMI) How to navigate the scope of practice question Clinical decision frameworks for real-world implementation Why force multipliers matter for the approaching workforce crisis FAQs for clinical guidance Read on or listen to the full Psychiatry Tomorrow episode below: The Neurobiological Case for GLP-1s for Mental Health GLP-1 isn't only produced in gut L-cells

The goal is not to force big meals

SO far I has been happy with the results which are visible in look and feel

The "clinically proven" claim is equally hollow, because no published peer-reviewed study has ever evaluated this specific product

The reduced appetite that makes Retatrutide effective also reduces thirst signals
